Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Virol ; 92(12): 3138-3143, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32531866

ABSTRACT

Group B Coxsackieviruses (CVB) include six serotypes (B1-6) responsible for a wide range of clinical diseases. Since no recent seroepidemiologic data are available in Italy, the study aim was to investigate CVB seroprevalence in a wide Italian population. The study retrospectively included 2459 subjects referring to a large academic hospital in Rome (Italy) in the period 2004-2016. Seroprevalence rates and neutralizing antibodies (nAb) titers were evaluated in relation to years of observation and subjects' characteristics. Positivity for at least one serotype was detected in 69.1% of individuals. Overall, the prevalent serotype was B4, followed by B3 (33.3%), B5 (26.2%), B1 (12.7%), B2 (11.0%), and B6 (1.7%). For B2, a significant decrease in seroprevalence over years was observed. Positivity to at least one virus was 25.2% in children aged 0 to 2 years, but significantly increased in preschool (3-5 years) (50.3%) and school (6-10 years) children (70.4%). Higher nAb responses for B3 and B4 were observed in children aged 3 to 5 years. A high overall CVB prevalence was found. Type-specific variations in prevalence over time probably reflect the fluctuations in circulation typical of Enteroviruses. Children are at greater risk for CVB infection given the high number of seronegative subjects aged 0 to 10 years.

2.
J Glob Antimicrob Resist ; 20: 298-303, 2020 03.
Article in English | MEDLINE | ID: mdl-31518723

ABSTRACT

OBJECTIVES: Transmitted drug resistance (TDR) and HIV-1 genetic diversity may affect treatment efficacy and clinical outcomes. Here we describe the circulating viral subtypes and estimate the prevalence of drug resistance among antiretroviral therapy (ART)-naïve patients attending Sapienza University Hospital (Rome, Italy) from 2006-2017. METHODS: Genotypic resistance testing (GRT) was performed on 668 ART-naïve patients for integrase (n = 52), protease and reverse transcriptase (n = 668) sequences. RESULTS: Twenty-one different HIV-1 subtypes and circulating recombinant forms (CRFs) were identified. Subtype B was the most common (67.1%), followed by CRF02_AG (8.4%), and subtypes C and F (both 6.0%). A significantly increase in the proportion of non-B strains (P < 0.001) and the rate of non-Italian patients was observed over time. The overall prevalence of TDR was 9.4% (NRTI, 4.2%; NNRTI, 5.8%; and PI, 1.0%) and was higher in subtype B strains. Transmitted INSTI mutations (Q148H and G140S) responsible for high-level resistance to raltegravir and elvitegravir and intermediate resistance to dolutegravir and bictegravir were found, for the first time, in two individuals. Minor or accessory INSTI mutations were detected in 17.3% of patients. No significant decrease in the prevalence of TDR was documented over time. CONCLUSION: The significant increase in non-B subtypes suggests that the molecular epidemiology of HIV-1 is changing. Detection of a major INSTI mutation in two ART-naïve patients highlights the importance of performing GRT before commencing treatment. This finding and the lack of a significant reduction in TDRs underline the importance of continuous surveillance of resistance mutations.


Subject(s)
Drug Resistance, Viral , HIV Infections/transmission , HIV-1/classification , Mutation , pol Gene Products, Human Immunodeficiency Virus/genetics , Adult , Anti-HIV Agents/pharmacology , Female , HIV Infections/drug therapy , HIV Integrase/genetics , HIV Protease/genetics , HIV Reverse Transcriptase/genetics , HIV-1/drug effects , HIV-1/genetics , Humans , Italy/epidemiology , Male , Middle Aged , Molecular Epidemiology , Phylogeny , Prevalence
3.
Int J Immunopathol Pharmacol ; 29(2): 308-19, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26936651

ABSTRACT

BACKGROUND: Allergic diseases are complex identities determined by an interplay of genetic and environmental factors, resulting in the clinical manifestation of the disease. So far in Italy, updated data about the prevalence and risk factors of respiratory and allergic diseases in preschool children are not available. METHODS: Children aged 3-5 years, attending four different nursery schools in an urban district of the city of Rome. A standardized questionnaire developed under the SIDRIA-2 protocol was administered to the parents of the children for the assessment of the potential risk factors and the outcomes. RESULTS: A total of 494 children were enrolled in the study; 289 of them (60.3%) performed a skin prick test (SPT). In the 12 months preceding the interviews, 15% of children experienced at least one episode of wheezing, 5.5% of allergic rhinitis, 11% of children had a doctor diagnosis of asthma, 12% of children who underwent the SPT were positive to at least one of the tested allergens, being diagnosed as atopic. The univariate analysis for the health outcomes of the study shows that asthma was positively associated with daycare attendance, mother's history of atopy, siblings' history of atopy, recurrent siblings' bronchitis, and dermatitis. Atopy was positively associated with mother's history of atopy and dermatitis, whereas there is a borderline protective association with recurrent siblings' bronchitis. CONCLUSIONS: This study represents a first comprehensive epidemiological evaluation of prevalence of respiratory and allergic diseases in children aged 3-5 years in the city of Rome and an updating of the evolution of allergic diseases.


Subject(s)
Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/etiology , Allergens/immunology , Asthma/epidemiology , Asthma/etiology , Bronchitis/epidemiology , Bronchitis/etiology , Child , Child, Preschool , Early Intervention, Educational/methods , Female , Humans , Male , Prevalence , Respiratory Sounds/immunology , Rhinitis, Allergic/epidemiology , Rhinitis, Allergic/etiology , Risk Factors , Rome/epidemiology , Skin Tests/methods , Surveys and Questionnaires
4.
BMC Pediatr ; 14: 156, 2014 Jun 20.
Article in English | MEDLINE | ID: mdl-24947584

ABSTRACT

BACKGROUND: Chronic granulomatous disease is a rare inherited disorder of the innate immune system. In patients with a clinical history of recurrent or persistent infections, especially infections caused by uncommon species, chronic granulomatous disease should be considered. CASE PRESENTATION: We report the case of a 5-year-old boy with a presumptive diagnosis of Crohn's disease with extraintestinal manifestations. Chronic granulomatous disease was suspected in this case after Serratia marcescens was isolated from a skin ulcer culture. Granulomas were confirmed on histology and chronic granulomatous disease was diagnosed. CONCLUSION: This case emphasizes the importance of high clinical suspicion of an alternative diagnosis of immune deficiency in patients with presumed inflammatory bowel disease and opportunistic infections, especially when disease occurs in early life.


Subject(s)
Crohn Disease/diagnosis , Granulomatous Disease, Chronic/diagnosis , Serratia Infections/etiology , Serratia marcescens/isolation & purification , Child, Preschool , Diagnosis, Differential , Granulomatous Disease, Chronic/complications , Humans , Male , Serratia Infections/diagnosis
5.
Ital J Pediatr ; 39: 77, 2013 Dec 10.
Article in English | MEDLINE | ID: mdl-24325793

ABSTRACT

BACKGROUND: Zygomycosis is a rare life-threatening fungal infection affecting mostly patients with predisposing conditions such as diabetes mellitus, immunodeficiency, haemochromatosis or major trauma. METHODS: We describe a case of rhinocerebral zygomycosis in a girl with type 1 diabetes and review previous published cases and treatment options. RESULTS: A 14-year-old girl with type 1 diabetes mellitus occurred with dental pain, facial swelling, ecchymosis and left eye decreased visual acuity, unresponsive to antibiotic therapy. The cultures of the sinusal mucosa were positive for fungal species belonging to the Zygomycetes. She performed antifungal therapy with posaconazole (POS) with a very slow improvement and a poor glycemic control, leading to blindness of the left eye. CONCLUSION: Our report adds further awareness on rhinocerebral zygomycosis and emphasizes on urgent diagnosis and timely management of this potentially fatal fungal infection through an adequate treatment.


Subject(s)
Blindness/etiology , Diabetes Mellitus, Type 1/complications , Fungemia/diagnosis , Meningitis, Fungal/diagnosis , Opportunistic Infections/diagnosis , Opportunistic Infections/microbiology , Zygomycosis/diagnosis , Adolescent , Antifungal Agents/therapeutic use , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 1/immunology , Disease Progression , Electromyography/methods , Female , Follow-Up Studies , Fungemia/drug therapy , Fungemia/microbiology , Humans , Immunocompromised Host , Magnetic Resonance Imaging/methods , Meningitis, Fungal/drug therapy , Meningitis, Fungal/microbiology , Nose Diseases/diagnosis , Nose Diseases/drug therapy , Nose Diseases/microbiology , Opportunistic Infections/drug therapy , Rare Diseases , Risk Assessment , Severity of Illness Index , Treatment Outcome , Triazoles/therapeutic use , Zygomycosis/drug therapy , Zygomycosis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...